SOUTH SAN FRANCISCO, Calif.--Terrapin Technologies here formed its first alliance with a company that uses bioinformatics when it entered into a collaboration with UK-based Pharmagene late last month to discover therapeutic agents to treat migraine headaches and disorders related to gastrointestinal motility, according to Rey Gomez, Terrapin's vice-president of research and development.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.